In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.

MLA

Wood, Michael A., et al. “In-Clinic Evaluation of the MiniMed 670G System ‘Suspend Before Low’ Feature in Children with Type 1 Diabetes.” Diabetes Technology & Therapeutics, vol. 20, no. 11, Nov. 2018, pp. 731–37. EBSCOhost, https://doi.org/10.1089/dia.2018.0209.

APA

Wood, M. A., Shulman, D. I., Forlenza, G. P., Bode, B. W., Pinhas-Hamiel, O., Buckingham, B. A., Kaiserman, K. B., Liljenquist, D. R., Bailey, T. S., Shin, J., Huang, S., Chen, X., Cordero, T. L., Lee, S. W., & Kaufman, F. R. (2018). In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes. Diabetes Technology & Therapeutics, 20(11), 731–737. https://doi.org/10.1089/dia.2018.0209

Chicago

Wood, Michael A, Dorothy I Shulman, Gregory P Forlenza, Bruce W Bode, Orit Pinhas-Hamiel, Bruce A Buckingham, Kevin B Kaiserman, et al. 2018. “In-Clinic Evaluation of the MiniMed 670G System ‘Suspend Before Low’ Feature in Children with Type 1 Diabetes.” Diabetes Technology & Therapeutics 20 (11): 731–37. doi:10.1089/dia.2018.0209.